(Q40566921)

21 September 2017

1 reference

title

Making the most out of six systematic sextant biopsies (English)

1 reference

21 September 2017

T A Stamey

1

1 reference

PubMed ID

7817477

21 September 2017

language of work or name

English

0 references

publication date

1 January 1995

1 reference

21 September 2017

1 reference

21 September 2017

45

1 reference

21 September 2017

2-12

1 reference

21 September 2017

1

1 reference

Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2895%2996168-2

7 January 2021

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2895%2996168-2

7 January 2021

Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2895%2996168-2

7 January 2021

Patterns of progression in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2895%2996168-2

7 January 2021

Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2895%2996168-2

7 January 2021

Latent carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2895%2996168-2

7 January 2021

Microcarcinoma in the prostate: Its association with duct-acinar dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2895%2996168-2

7 January 2021

Identification of insignificant prostate cancers: analysis of preoperative parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2895%2996168-2

7 January 2021

Tumor volume and stage in carcinoma of the prostate detected by elevations in prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2895%2996168-2

7 January 2021

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2895%2996168-2

7 January 2021

Stage A versus stage B adenocarcinoma of the prostate: morphological comparison and biological significance.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2895%2996168-2

7 January 2021

The role of perineural space invasion in the local spread of prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2895%2996168-2

7 January 2021

Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2895%2996168-2

7 January 2021

Large, organ confined, impalpable transition zone prostate cancer: association with metastatic levels of prostate specific antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2895%2996168-2

7 January 2021

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2895%2996168-2

7 January 2021

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2895%2996168-2

7 January 2021

10.1016/S0090-4295(95)96168-2

Identifiers

DOI

1 reference

21 September 2017

1 reference

PubMed ID

7817477